Artis BioSolutions, a company founded to streamline the discovery, development and production of genetic medicines, has emerged from stealth and launched. Simultaneously, it has announced its acquisition of Landmark Bio, a cell and gene therapy manufacturing company specializing in translational research, process development, and manufacturing technologies. As a part of Artis, Landmark Bio will continue to operate as a distinct entity, focused on accelerating therapeutic development from prec...